Skip to content

Thioctic acid

ALIMENTARY TRACT AND METABOLISM

Also known as: (RS)-Lipoic acid, alpha lipoic acid, alpha-lipoic acid, lipoic acid, lipothion, thioctacid, thioctsan, tioctacid

FDA approvedATC A16AX01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Thioctic acid is a drug catalogued in DrugCentral. DrugCentral lists 4 molecular targets, including ACHE, glmU and SAE1|UBA2. Recorded indications include Diabetic peripheral neuropathy.

  • Molecular targets: ACHE, glmU, SAE1|UBA2 and TARDBP (4 listed in DrugCentral).
  • Indications: Diabetic peripheral neuropathy.
  • ATC code: A16AX01 (Various alimentary tract and metabolism products).
  • Molecular formula: C8H14O2S2; molecular weight 206.32 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Diabetic peripheral neuropathy

Contraindications (3)

  • Disease of liver
  • Low blood pressure
  • Obstruction of bile duct

Mechanism & targets

Molecular targets (4)

TargetGeneActionActivity
AcetylcholinesteraseACHEunknownIC50 9.00
Bifunctional protein GlmUglmUunknownIC50 5.41
SUMO-activating enzymeSAE1|UBA2unknownIC50 5.32
TAR DNA-binding protein 43TARDBPunknownIC50 4.70

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA——

ATC classification

ATC codeTherapeutic hierarchy
A16AX01ALIMENTARY TRACT AND METABOLISM › OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS › OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS › Various alimentary tract and metabolism products

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Hepatic necrosis167.9
Hepatic encephalopathy134.4
Hepatotoxicity118.0
Hepatic cirrhosis105.5
Drug-induced liver injury102.0
Drug interaction74.7
Basal cell carcinoma58.2

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Thioctic acid is on its molecule page.

Molecular formulaC8H14O2S2
Molecular weight206.32 g/mol
CAS number1077-28-7
InChIKeyAGBQKNBQESQNJD-UHFFFAOYSA-N
PubChem CID864
OC(=O)CCCCC1CCSS1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Thioctic acid used for?

DrugCentral lists the following indications for Thioctic acid: Diabetic peripheral neuropathy.

How does Thioctic acid work?

Its molecular targets in DrugCentral include ACHE, glmU, SAE1|UBA2 and TARDBP.

What is the chemical formula of Thioctic acid?

Thioctic acid has the molecular formula C8H14O2S2 and a molecular weight of 206.32 g/mol.

Browse: all drugs starting with T · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyFDA
Targets4
Indications1
FormulaC8H14O2S2
DrugCentral ID4732
Interactive profile